Catalyst Wire Dossier Catalyst Wire Dossier

Rodatristat Ethyl

rodatristat ethyl · Altavant Sciences GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rodatristat Ethyl, covering 2025-06-04 to 2025-06-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (Core OLE) [Phase 2]

See pricing